The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Advanced glycation end products activate Smad signaling via TGF‐β‐dependent and ‐independent mechanisms: implications for diabetic renal and vascular disease
Abstract
While it is thought that advanced glycation end products (AGEs) act by stimulating transforming growth factor (TGF)‐β to mediate diabetic injury, we report that AGEs can activate TGF‐β signaling, Smads, and mediate diabetic scarring directly and independently of TGF‐β. AGEs activate Smad2/3 in renal and vascular cells at 5 min, peaking over 15–30 min before TGF‐β synthesis at 24 h and occurs in TGF‐β receptor I and II mutant cells. This is mediated by RAGE and ERK/p38 mitogen‐activated protein kinases (MAPKs). In addition, AGEs also activate Smads at 24 h via the classic TGF‐β‐dependent pathway. A substantial inhibition of AGE‐ induced Smad activation and collagen synthesis by ERK/p38 MAPK inhibitors, but not by TGF‐β blockade, suggests that the MAPK‐Smad signaling crosstalk pathway is a key mechanism in diabetic scarring. Prevention of AGE‐induced Smad activation and collagen synthesis by overexpression of Smad7 indicates that Smad signaling may play a critical role in diabetic complications. This is further supported by the findings that activation of Smad2/3 in human diabetic nephropathy and vasculopathy is associated with local deposition of AGEs and up‐ regulation of RAGE. Thus, AGEs act by activating Smad signaling to mediate diabetic complications via both TGF‐β‐dependent and ‐independent pathways, shedding new light on the pathogenesis of diabetic organ injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Nakao, A., Afrakhte, M., Morn, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N.-E., Heldin, C.-H., et al. (1997) · Nature · doi:10.1038/39369 · Cited by 1,809
Controlling TGF-beta signaling.
Massagué, J., & Chen, Y. (2000) · PubMed · Cited by 1,780
Massagué, J., & Chen, Y.-G. (2000) · Genes & Development · doi:10.1101/gad.14.6.627 · Cited by 1,575
Neeper, M., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. C., Elliston, K., Stern, D., & Shaw, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,541
TGFβ signals through a heteromeric protein kinase receptor complex
Wrana, J. L., Attisano, L., Cárcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X.-F., & Massague, J. (1992) · Cell · doi:10.1016/0092-8674(92)90395-s · Cited by 1,526
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
Schmidt, A. M., Yan, S. D., Yan, S. F., & Stern, D. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14002 · Cited by 1,253
Smad7 Binds to Smurf2 to Form an E3 Ubiquitin Ligase that Targets the TGFβ Receptor for Degradation
Kavsak, P., Rasmussen, R. K., Causing, C. G., Bonni, S., Zhu, H., Thomsen, G. H., & Wrana, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00134-9 · Cited by 1,205
Self-citationPark, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Chow, W. S., Stern, D., & Schmidt, A. M. (1998) · Nature Medicine · doi:10.1038/2012 · Cited by 1,104
Ziyadeh, F. N., Hoffman, B. B., Han, D. C., Iglesias-de la Cruz, M. C., Hong, S. W., Isono, M., Chen, S., McGowan, T. A., & Sharma, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120055097 · Cited by 907
Lander, H. M., Tauras, J. M., Ogiste, J. S., Hori, O., Moss, R. A., & Schmidt, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17810 · Cited by 813
Sharma, K., Jin, Y., Guo, J., & Ziyadeh, F. N. (1996) · Diabetes · doi:10.2337/diab.45.4.522 · Cited by 662
Schmidt, A. M., Hori, O., Brett, J., Yan, S. D., Wautier, J. L., & Stern, D. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.10.1521 · Cited by 635
Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice
Yamamoto, Y., Kato, I., Doi, T., Yonekura, H., Ohashi, S., Takeuchi, M., Watanabe, T., Yamagishi, S.-I., Sakurai, S., Takasawa, S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11771 · Cited by 475
Oldfield, M. D., Bach, L. A., Forbes, J. M., Nikolic-Paterson, D., McRobert, A., Thallas, V., Atkins, R. C., Osicka, T., Jerums, G., & Cooper, M. E. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11951 · Cited by 472
Self-citationSMADs: mediators and regulators of TGF-β signaling
Kretzschmar, M., & Massagué, J. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80069-5 · Cited by 467
An agent cleaving glucose-derived protein crosslinks in vitro and in vivo
Vasan, S., Zhang, X., Zhang, X., Kapurniotu, A., Bernhagen, J., Teichberg, S., Basgen, J., Wagle, D., Shih, D., Terlecky, I., et al. (1996) · Nature · doi:10.1038/382275a0 · Cited by 466
Vlassara, H., Li, Y. M., Imani, F., Wojciechowicz, D., Yang, Z., Liu, F.-T., & Cerami, A. (1995) · Molecular Medicine · doi:10.1007/bf03401604 · Cited by 421
Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice
Nakao, A., Fujii, M., Matsumura, R., Kumano, K., Saito, Y., Miyazono, K., & Iwamoto, I. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6094 · Cited by 405
Bierhaus, A., Chevion, S., Chevion, M., Hofmann, M., Quehenberger, P., Illmer, T., Luther, T., Berentshtein, E., Tritschler, H., Müller, M., et al. (1997) · Diabetes · doi:10.2337/diab.46.9.1481 · Cited by 371
Lan, H. Y., Mu, W., Nikolic-Paterson, D. J., & Atkins, R. C. (1995) · Journal of Histochemistry & Cytochemistry · doi:10.1177/43.1.7822770 · Cited by 359
Self-citationYeh, C.-H., Sturgis, L., Haidacher, J., Zhang, X.-N., Sherwood, S. J., Bjercke, R. J., Juhasz, O., Crow, M. T., Tilton, R. G., & Denner, L. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1495 · Cited by 326
Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease.
Yang, C. W., Vlassara, H., Peten, E. P., He, C. J., Striker, G. E., & Striker, L. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9436 · Cited by 294
Watanabe, H., de Caestecker, M. P., & Yamada, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005724200 · Cited by 273
Mechanisms of diabetic vasculopathy: an overview
Cooper, M. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)01323-6 · Cited by 267
Self-citationLi, J. H., Zhu, H.-J., Huang, X. R., Lai, K. N., Johnson, R. J., & Lan, H. Y. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000014252.37680.e4 · Cited by 245
Self-citationTransforming growth factor β contributes to progressive diabetic nephropathy
Reeves, W. B., & Andreoli, T. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.7667 · Cited by 225
Advanced glycosylation end products in diabetic renal and vascular disease
Bucala, R., & Vlassara, H. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90051-9 · Cited by 211
Won Hong, S., Isono, M., Chen, S., Iglesias-de la Cruz, M. C., Han, D. C., & Ziyadeh, F. N. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64121-1 · Cited by 194
Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products.
Rumble, J. R., Cooper, M. E., Soulis, T., Cox, A., Wu, L., Youssef, S., Jasik, M., Jerums, G., & Gilbert, R. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119229 · Cited by 193
Self-citationYang, Z., Makita, Z., Horii, Y., Brunelle, S., Cerami, A., Sehajpal, P., Suthanthiran, M., & Vlassara, H. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.515 · Cited by 192
Transforming growth factor β signaling mediators and modulators
Zimmerman, C. M., & Padgett, R. W. (2000) · Gene · doi:10.1016/s0378-1119(00)00162-1 · Cited by 174
Throckmorton, D. C., Brogden, A. P., Min, B., Rasmussen, H., & Kashgarian, M. (1995) · Kidney International · doi:10.1038/ki.1995.274 · Cited by 174
Schmidt, A. M., & Stern, D. M. (2000) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00311-8 · Cited by 167
Renoprotective effects of a novel inhibitor of advanced glycation
Forbes, J. M., Soulis, T., Thallas, V., Panagiotopoulos, S., Long, D. M., Vasan, S., Wagle, D., Jerums, G., & Cooper, M. E. (2001) · Diabetologia · doi:10.1007/s001250051587 · Cited by 161
Self-citationKelly, D. J., Gilbert, R. E., Cox, A. J., Soulis, T., Jerums, G., & Cooper, M. E. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12102098 · Cited by 128
Self-citationBlanchette, F., Rivard, N., Rudd, P. A., Grondin, F., Attisano, L., & Dubois, C. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100093200 · Cited by 121
Transforming Growth Factor β in Diabetic Nephropathy
Border, W. A., Yamamoto, T., & Noble, N. A. (1996) · Diabetes/Metabolism Reviews · doi:10.1002/(sici)1099-0895(199612)12:4<309::aid-dmr172>3.0.co;2-a · Cited by 106
Han, D. C., Hoffman, B. B., Hong, S. W., Guo, J., & Ziyadeh, F. N. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.4.f628 · Cited by 105
Smad7 Differentially Regulates Transforming Growth Factor β-mediated Signaling Pathways
Zhu, H., Iaria, J., & Sizeland, A. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32258 · Cited by 86
Self-citationHill‐Kapturczak, N., Truong, L., Thamilselvan, V., Visner, G. A., Nick, H. S., & Agarwal, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006621200 · Cited by 85
Self-citationZhao, J., Shi, W., Chen, H., & Warburton, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002433200 · Cited by 75
Administration of AGEs in vivo induces extracellular matrix gene expression
Striker, L. J., & Striker, G. E. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.supp5.62 · Cited by 61
Smad7 is a TGF-β-inducible attenuator of Smad2/3-mediated inhibition of embryonic lung morphogenesis
Zhao, J., Crowe, D. L., Castillo, C., Wuenschell, C. W., Chai, Y., & Warburton, D. (2000) · Mechanisms of Development · doi:10.1016/s0925-4773(00)00281-1 · Cited by 46
Blockade of the Effects of TGF-β1 on Mesangial Cells by Overexpression of Smad7
Chen, R., Huang, C., Morinelli, T. A., Trojanowska, M., & Paul, R. V. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v134887 · Cited by 43
Cited by
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
Self-citationMechanisms, Pathophysiology, and Therapy of Arterial Stiffness
Zieman, S. J., Melenovsky, V., & Kass, D. A. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160548.78317.29 · Cited by 1,854
González, P., Lozano, P., Ros, G., & Solano, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119352 · Cited by 777
TGF-β/Smad signaling in renal fibrosis
Meng, X.-M., Tang, P. M.-K., Li, J., & Lan, H. Y. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00082 · Cited by 666
Self-citationDiverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation
Lan, H. Y. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1056 · Cited by 652
Self-citation
Metadata
- Authors
- Li, J. H., Huang, X. R., Zhu, H., Oldfield, M., Cooper, M., Truong, L. D., Johnson, R. J., & Lan, H. Y.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2003-04-22
- Volume
- 18
- Issue
- 1
- Pages
- 176-178
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2147068335
- Cited by
- 264
- References
- 44
- FWCI
- 5.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.